SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
Clinical trials for SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS explained in plain language.
Never miss a new study
Get alerted when new SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS trials appear
Sign up with your email to follow new studies for SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo tackles rare immune storm in adults
Disease control CompletedThis study tested whether a drug called interferon-gamma monoclonal antibody, when combined with the steroid dexamethasone, can help adults with a severe and hard-to-treat immune condition called secondary hemophagocytic lymphohistiocytosis (HLH). The study included 22 participan…
Matched conditions: SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
Sponsor: Fudan University • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New drug targets deadly immune storm in rare inflammatory diseases
Disease control CompletedThis study tested a drug called emapalumab in 33 children and adults with a life-threatening immune overreaction (macrophage activation syndrome) linked to Still's disease or lupus. The goal was to see if the drug could safely calm the immune system and improve blood markers and …
Matched conditions: SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
Phase: PHASE3 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated May 04, 2026 16:19 UTC